Development | Vaccine | Against Influenza
Against Influenza
A universal vaccine providing protection against existing and potential reassortant influenza strains has been developed.
Mechanism of Action
The vaccine induces immunity against various subtypes of influenza A and B viruses, including those that may emerge from reassortment. Its safety is ensured by the recombinant protein component, avoiding risks associated with introducing even inactivated virus.
Against Influenza
A universal vaccine providing protection against existing and potential reassortant influenza strains has been developed.
Mechanism of Action
The vaccine induces immunity against various subtypes of influenza A and B viruses, including those that may emerge from reassortment. Its safety is ensured by the recombinant protein component, avoiding risks associated with introducing even inactivated virus.
Patents for Inventions
Application No. 027463 – Polyvalent Influenza Vaccine Based on Hybrid Protein
Application No. 2531235 – Polyvalent Influenza Vaccine Based on Hybrid Protein
Application No. 24288 – Certificado de Patente de Invención
Application No. 115895 – Polyvalent Influenza Vaccine Based on Hybrid Protein
Application No. 2956168 – European Patent
Application No. US9480737 – Patent for Invention (USA)
Application No. 104994871 – Patent for Invention (China)
Application No. 1216499 – Patent for Invention (Hong Kong)
Mexico No. 2015010623 (filed 17.08.2015)
Vietnam No. 1-2015-03347 (filed 11.09.2015)
Thailand No. 1501004605 (filed 14.08.2015)
Nicaragua No. 2015-00109 (filed 14.08.2015)
Patent Applications
Awards for Development
2018 – International Fair of Technics and Technical Achievements, Belgrade
2018 – Archimedes Salon, Moscow – Diploma, Gold Medal
2018 – New Time Salon, Sevastopol – Diploma, Silver Medal
Leave your request, and we will contact you.
Would you like us to develop a custom drug?
Сообщение об успешной отправке!
Phone:
Email:
